AI assistant
Sending…
Precipio, Inc. — Director's Dealing 2012
Feb 21, 2012
34807_dirs_2012-02-21_7db88492-e290-4c4c-878c-84a8e30e402c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: TRANSGENOMIC INC (TBIO.OB)
CIK: 0001043961
Period of Report: 2012-02-15
Reporting Person: Markin Rodney S (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-15 | Purchase Option | $1.45 | A | 25000 | Acquired | 2022-02-14 | Common Stock (25000) | Direct |
Footnotes
F1: Common Stock, par value $.01 per share of Transgenomic, Inc.
More from Precipio, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 6
Earnings Release
2026
Feb 27
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Jan 26
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20